Related Experiment Video
Updated: May 27, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Type 2 diabetes and cardiovascular risk factors
Insights
Diabetes significantly increases cardiovascular disease risk, especially for type 2 diabetes patients. While hyperglycemia links to microvascular issues, evidence for glycemic control reducing cardiovascular risk remains limited.
Area of Science:
- Endocrinology
- Cardiology
- Metabolic Diseases
Background:
- Diabetes mellitus is a major risk factor for cardiovascular (CV) morbidity and mortality.
- Individuals with type 2 diabetes face a two- to four-fold higher risk of CV disease compared to non-diabetic individuals.
- Hypertension, hyperlipidemia, and diabetes are independent contributors to increased CV disease risk.
Discussion:
- Long-term hyperglycemia demonstrates a stronger correlation with microvascular complications than macrovascular ones.
- The association between diabetes and cardiovascular disease is multifactorial, involving metabolic and hemodynamic factors.
- Understanding these associations is crucial for effective patient management and risk stratification.
Key Insights:
- Type 2 diabetes confers a substantially elevated risk for cardiovascular complications.
- Glycemic control's direct impact on reducing macrovascular CV risk requires further investigation.
- Microvascular complications are more strongly linked to sustained hyperglycemia.
Outlook:
- Further research is needed to clarify the role of glycemic control in mitigating cardiovascular risk in diabetic patients.
- Investigating the interplay between hyperglycemia, hypertension, and hyperlipidemia in CV disease progression is essential.
- Developing targeted therapies for both microvascular and macrovascular complications in diabetes is a priority.
Abstract:
Diabetes is associated with higher cardiovascular morbidity and mortality. Hypertension, hyperlipidemia and diabetes are independently associated with increased risk of cardiovascular (CV) disease. Subjects with type 2 diabetes are at two- to four-fold increased risk of CV disease compared to those without diabetes. Long-term hyperglycemia is much more closely associated with microvascular complications than macrovascular complications. There is a lack of adequate evidence that improvement in glycemic control decreases CV risk.
Related Concept Videos
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
Coronary Artery Disease I: Introduction
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
